Skip to content

Zafran

Exposure management platform that validates which vulnerabilities are actually exploitable given deployed security controls, to cut remediation noise.

Visit Website ↗ + Add to Compare Claim This Company
63/100Incremental Innovator

Overview

Zafran sells an exposure management platform that sits on top of existing vulnerability scanners (Tenable, Qualys, and others) and asks a narrower question: given the security controls an organization already has deployed, which flagged vulnerabilities are actually exploitable right now? The company takes an agentless, API-based approach, pulling data from scanners, EDR, network, and cloud tools to build a picture of real exposure rather than raw vulnerability counts.

The pitch is aimed squarely at alert fatigue: security teams routinely triage thousands of ‘critical’ findings that are already mitigated by an existing control, and Zafran’s platform is designed to filter those out and surface what genuinely needs attention. It has expanded from pure risk scoring into automated remediation workflows since emerging from stealth.

Founded in New York in 2022, Zafran raised a $60 million Series C in 2026 led by Menlo Ventures, with Cyberstarts, Sequoia Capital, and other investors participating, bringing total funding to roughly $130 million.

Innovation Matrix Assessment

Innovation Velocity 7/10

Raised three funding rounds totaling roughly $130M in about four years, expanding from an exposure-scoring tool into a full risk-and-mitigation platform.

Operational Value 7/10

Agentless integration with widely used scanners (Tenable, Qualys) and security controls lets teams cut through duplicate/mitigated findings, directly reducing remediation workload if it performs as described.

Market Momentum 7/10

Series C of $60M led by Menlo Ventures with Sequoia Capital and Cyberstarts participating, per SecurityWeek, bringing total funding to $130M across five rounds.

Category Disruption 6/10

Adds a control-aware validation layer on top of the existing vulnerability management stack rather than replacing it; useful consolidation in a crowded exposure-management category, not a new paradigm.

Real-World Efficacy 4/10

No named customer case studies or independent efficacy testing were found; the company states it serves finance and tech enterprises without naming them.

Enduring Relevance 7/10

Exposure prioritization remains a persistent CISO problem as vulnerability volumes keep outpacing remediation capacity.

Why CISOs Should Care

Cuts the volume of vulnerability alerts a SOC has to chase by filtering out findings already neutralized by existing controls, freeing remediation effort for what's genuinely exploitable.

What Makes It Different

Agentless and control-aware: it reasons about an organization's actual deployed defenses rather than scoring vulnerabilities in isolation from CVSS data alone.

The Matrix Verdict

63/100 — INCREMENTAL INNOVATOR

An Incremental Innovator: a well-funded, credibly backed exposure-management platform solving a real prioritization problem, but operating in a crowded category without independently verified efficacy evidence yet.

Editorial Note: Claims vs. Verified Findings

Funding rounds, investors, and founding details are independently confirmed via SecurityWeek and Crunchbase. Claims about reducing remediation effort and specific customer outcomes are vendor-stated and not independently tested.

Sources